Back to TEVA Stock Lookup

Teva Pharma (TEVA) –

Oct 30, 2014 04:01 PM OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2014
Oct 30, 2014 02:00 PM Teva Pharma (TEVA) Price Target Raised to $64 at Deutsche Bank
Oct 30, 2014 10:32 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 30
Oct 30, 2014 07:10 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 30
Oct 30, 2014 07:04 AM Teva Pharma (TEVA) Tops Q3 EPS by 9c
Oct 30, 2014 07:03 AM Teva Reports Third Quarter 2014 Results
Oct 29, 2014 03:47 PM Trading Radar for 10/30: GoPro (GPRO), MasterCard (MA), LinkedIn (LNKD), Starbucks (SBUX) Report
Oct 14, 2014 12:48 PM Standpoint Research Upgrades Teva Pharma (TEVA) to Buy
Oct 9, 2014 04:07 PM Alexza Pharma (ALXA) Updates on Commercial Progress of ADASUVE in U.S. (TEVA)
Oct 8, 2014 10:06 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 08
Oct 8, 2014 08:08 AM Teva Pharma (TEVA) Initiates Rolling NDA for CEP-33237
Oct 8, 2014 08:00 AM Teva Announces Initiation of New Drug Application and Positive Results from Second Human Abuse Liability Study for CEP-33237 (Hydrocodone Bitartrate) Extended-Release Tablets
Oct 6, 2014 02:21 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 06
Oct 6, 2014 01:59 PM Teva to Report Third Quarter 2014 Financial Results on October 30, 2014
Oct 6, 2014 09:12 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 06
Oct 6, 2014 08:39 AM Teva Pharma (TEVA) Completes Review of Core Therapeutic Areas; Will Discontinue 14 Pipeline Products
Oct 6, 2014 08:30 AM Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
Oct 6, 2014 08:00 AM BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Files an IND with the FDA for OpRegen® Designed to Treat Patients with Dry-AMD
Oct 3, 2014 01:24 PM Teva Pharma (TEVA) / Mylan (MYL) Combo Unlikely, Says Wells Fargo
Oct 3, 2014 08:04 AM Goldman Sachs Comments on Mylan (MYL) Following Yesterday's Rumors (TEVA) (ABT)
Oct 2, 2014 11:15 AM Standpoint Research Downgrades Teva Pharma (TEVA) to Hold
Sep 17, 2014 09:00 AM BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates the Safety and Efficacy of OpRegen® in Preclinical Animal Studies
Sep 16, 2014 06:30 AM OncoGenex Announces Completion of Patient Enrollment in the Phase 3 AFFINITY Trial of Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Men with Metastatic Castrate-R
Sep 12, 2014 09:18 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 12
Sep 12, 2014 09:00 AM Teva Presents Gene Expression Analysis at Joint Actrims-Ectrims Meeting Demonstrating Copaxone® (Glatiramer Acetate Injection) Has a Complex Profile
Sep 12, 2014 08:47 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 12
Sep 12, 2014 08:14 AM Teva Pharma (TEVA), Active Biotech Update on Safety of Laquinimod Phase 2 as RRMS Treatment
Sep 12, 2014 08:00 AM Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Sep 11, 2014 11:21 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 11
Sep 11, 2014 09:30 AM Teva Pharma (TEVA) Reports GLACIER Study Primary Endpoint Achieved
Sep 11, 2014 09:29 AM Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to D
Sep 10, 2014 02:30 PM Teva Pharma (TEVA) Reports Health Canada Approves Application for Generic Cipralex
Sep 8, 2014 09:48 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 08
Sep 8, 2014 08:04 AM Teva Pharma (TEVA) Issues Positive Update from Reslizumab Phase III
Sep 8, 2014 08:00 AM Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia
Sep 4, 2014 04:38 PM ISI Group Starts Teva Pharma (TEVA) at Buy
Sep 4, 2014 10:43 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 04
Sep 4, 2014 10:26 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 04
Sep 4, 2014 08:06 AM Teva Pharma (TEVA) Launches Generic Baraclude Tabs (BMY)
Sep 4, 2014 08:00 AM Teva Announces Launch of Generic Baraclude® Tablets, 0.5mg and 1mg, in the United States
Sep 4, 2014 08:00 AM Teva to Present at the Morgan Stanley Global Healthcare Conference
Sep 3, 2014 09:57 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 03
Sep 3, 2014 09:03 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 03
Sep 3, 2014 08:54 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 03
Sep 3, 2014 08:00 AM Teva Launches SYNCareTM Home Administration Support Program for Patients on SYNRIBO® (Omacetaxine Mepesuccinate) for Injection
Sep 3, 2014 08:00 AM Data to be Presented at MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva’s Commitment to Developing Solutions to Meet the Needs of the Multiple Sclerosis Community
Sep 3, 2014 06:21 AM Teva Pharma (TEVA) Receives Favorable Verdict from U.K. Court in Patent Case vs AstraZeneca (AZN)
Sep 3, 2014 02:00 AM Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
Sep 2, 2014 08:49 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 02
Sep 2, 2014 08:01 AM Teva’s Reslizumab Delivers Clinically and Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase III Studies

Back to TEVA Stock Lookup